Medical Cyclotron Market to Surge from USD 247.3M in 2025 to USD 636.7M by 2035, Driven by Rising PET & SPECT Demand

Medical Cyclotron Market

Medical cyclotron market to grow at 6.4% CAGR through 2035, fueled by radiopharmaceutical demand, cancer diagnostics, and expanding nuclear medicine facilities.

Cyclotron technology is redefining care pathways by enabling real-time access to life-saving diagnostic isotopes, strengthening global precision healthcare systems.”

— Sabyasachi Ghosh

FRANCE, November 7, 2025 /EINPresswire.com/ -- The global medical cyclotron market is projected to experience robust growth over the next decade, rising from an estimated value of USD 247.3 million in 2025 to USD 636.7 million by 2035, at a CAGR of 6.4%. This growth trajectory follows rising demand for diagnostic imaging procedures and radiopharmaceuticals used in cancer, neurological, and cardiovascular disease management across key global markets including the United States, Europe, Asia Pacific, and Saudi Arabia.

Medical cyclotrons play a critical role in producing radionuclides used in PET (Positron Emission Tomography) and SPECT (Single Photon Emission Computed Tomography) imaging. These imaging modalities are essential for early disease detection, precision diagnosis, and targeted treatment planning. With neurodegenerative and oncological disorders increasing worldwide, medical cyclotrons have become indispensable to modern healthcare infrastructures.

In 2024, global medical cyclotron revenue reached USD 232.4 million, driven by increased adoption of nuclear medicine technologies. The installed base of cyclotrons is expected to expand steadily as hospitals, research institutes, and pharmaceutical manufacturers scale radiopharmaceutical production.

Explore trends before investing — request a sample report today!:- https://www.futuremarketinsights.com/reports/sample/rep-gb-4292

Key Market Drivers

One of the core accelerators of market growth is the steep rise in PET and SPECT imaging procedures. The World Health Organization (WHO) has reported a continuing surge in global neurological disease prevalence. For example, Alzheimer's disease currently affects over 87 million people, expected to triple by 2050. Similarly, Parkinson’s disease cases exceeded 8.5 million globally in 2019, marking an 81% increase since 2000. Such epidemiological patterns underscore the urgent need for early and accurate diagnostic solutions, catalyzing the adoption of cyclotron-produced radionuclides.

In oncology, advancements in radiotracer development—especially Gallium-68 (Ga-68) based PSMA tracers for prostate cancer detection—have significantly boosted cyclotron installations. The IAEA reports that cyclotron production of Ga-68 yields substantially higher output compared to traditional generator systems, making cyclotrons more economical and scalable for healthcare providers.

Market Segment Insights

• Product Type: Ring Cyclotrons are projected to hold 55.8% market share in 2025 due to their high-efficiency production capabilities and broad isotope support.
• End User: Pharmaceutical companies are expected to dominate the market with 58.2% share, as demand intensifies for radiopharmaceutical innovation and large-scale supply.

Regional Growth Landscape

• United States: Expected 1.3% CAGR, supported by strong radiopharmaceutical R&D and FDA-backed innovation.
• United Kingdom: Growing Parkinson’s burden is driving adoption of PET-based diagnosis, supporting 1.5% CAGR.
• China: Set for 4.2% CAGR, fueled by government investment in nuclear medicine infrastructure.
• India: Anticipated 4.8% CAGR, driven by rising cancer care access and decentralized diagnostics.
• Saudi Arabia & GCC: Increased healthcare modernization and oncology program expansion are accelerating cyclotron deployment in specialized centers.

Emerging Trend: Compact Cyclotron Adoption in Developing Markets

Compact cyclotrons are gaining traction due to lower installation cost, smaller footprint, and simplified logistics, allowing localized radioisotope production in regions with limited infrastructure. This shift reduces reliance on imported isotopes that degrade during transport, improving clinical efficiency and patient outcomes.

Click Here to Purchase the Report:- https://www.futuremarketinsights.com/checkout/4292

Industry Structure and Competitive Outlook

The market is moderately concentrated, led by Tier-1 companies including:
Sumitomo Heavy Industries, GE Healthcare, Siemens AG, Varian Medical Systems, and IBA RadioPharma Solutions.

Tier-2 players such as Advanced Cyclotron Systems Inc., Ionetix Corporation, and Isosolution Inc. are driving innovation in compact systems and facility-specific configurations.

Recent strategic developments include:

• Siemens Healthineers’ acquisition of Varian, integrating cyclotron technology into advanced oncology systems.
• IBA RadioPharma Solutions partnerships expanding isotope production networks in the United States.
• Sumitomo and GE Healthcare introducing next-gen compact cyclotron models optimized for decentralized radiopharmaceutical production.

As precision medicine and nuclear diagnostics continue to shape global healthcare strategies, medical cyclotrons will remain central to advancing early detection and targeted therapeutic solutions.

Latest Research Report:-

Caprolactam Market
https://www.futuremarketinsights.com/reports/caprolactam-market

Plastic Tubes for Effervescent Tablets Market
https://www.futuremarketinsights.com/reports/plastic-tubes-for-effervescent-tablets-market

Vegan Vitamin D3 Supplements Market
https://www.futuremarketinsights.com/reports/vegan-vitamin-d3-supplements-market

Why Choose FMI Empowering Decisions that Drive Real-World Outcomes:- https://www.futuremarketinsights.com/why-fmi s

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analystsworldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Sudip Saha
Future Market Insights Inc.
+1 347-918-3531
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.